Skip to content
Zamenis

MABIS by Zamenis

Flagship product · TRL 6

A portable, non-invasive medical device for complementary screening of suspicious regions in breast tissue, with no ionizing radiation or compression.

Bring MABIS to my institutionSee clinical evidence

What is MABIS?

MABIS (Microwave Analyzer for Breast Imaging Scanning) is a portable medical device that uses ultra-wideband (UWB, 1–8 GHz) radar to analyze the dielectric contrast between tissues. An adaptable bra with 32 electromagnetic sensors conforms to each patient’s morphology, connected to a processing unit housed in a medical-case format.

Detail of the MABIS unit: open case with the scanning software on screen

How it works

The full procedure takes place in-office, with no special preparation for the patient.

  1. 1

    Bra fitting

    The 32 electromagnetic sensors are positioned over the breast tissue using a bra that adapts to each patient’s morphology.

  2. 2

    Scanning

    The UWB radar (1–8 GHz) measures the dielectric contrast between tissues, with no ionizing radiation or breast compression.

  3. 3

    Image reconstruction

    DAS/DMAS reconstruction algorithms convert the radar signals into 2D/3D maps of the scanned tissue.

  4. 4

    Report and follow-up

    An AI-assisted report identifies suspicious regions; the patient and medical staff access results through a remote digital platform.

Ajuste del brasier adaptable con sensores electromagnéticos sobre el maniquí de pruebas

Estimated duration: ~12 minutes per breast · ~60 minutes for the full visit.

Safety and patient experience

FeatureMABISMammographyUltrasoundMRI
Ionizing radiation
Breast compression
PortableSuitcase formatPartial
Reference equipment priceUSD 20,000*~USD 500,000~USD 100,000~USD 1,000,000
Connectivity and remote reportsLimitedLimitedLimited

*Reference equipment prices; they may vary by configuration and market.

0

95% of comfort reported by users

Results from ongoing clinical trials. Device under validation, pending DIGEMID regulatory authorization.

Two women smile next to the MABIS roll-up banner outdoors, holding information leaflets
Participants at a MABIS field campaign

Clinical evidence

0

patients in preclinical and clinical trials

0

specificity

0

sensitivity

0

comfort reported by users

Phase 2 clinical trials at AUNA clinics, in collaboration with IREN-SUR hospital. MABIS is positioned as a complement to conventional methods, not a replacement.

Results from ongoing clinical trials. Device under validation, pending DIGEMID regulatory authorization.

Clinical validation program

MABIS is in Phase 2 clinical trials at AUNA clinics, in collaboration with IREN-SUR hospital. The study compares the system’s findings against the conventional reference methods —mammography, ultrasound, tomography and biopsy— under a standardized data collection protocol.

Ongoing clinical study. MABIS is undergoing validation, pending DIGEMID regulatory authorization.

Technical specifications

TechnologyUltra-wideband (UWB) radar, 1–8 GHz
Sensors32 electromagnetic sensors
FormatPortable unit in a medical case
Maximum power5 dBm (3 mW)
Image processingDAS/DMAS algorithms → 2D/3D maps
ReportsAI-assisted, plus a remote-access digital platform
Duration~12 min per breast · ~60 min full visit
Technology readinessTRL 6

Intellectual property

  • Utility model patent filed with INDECOPI — File No. 003065-2024/DIN.
  • International PCT application — File No. PCT/PE2025/050037.
  • MABIS trademark registered with INDECOPI (class 10) — Certificate No. 00361748, Resolution No. 025980-2024/DSD-INDECOPI. Licensed by UCSP to Zamenis.

Scientific backing

MABIS is built on in-house research from the UCSP radiofrequency group, backed by peer-reviewed scientific publications:

E. San Román's publications on IEEE Xplore

Looking to bring MABIS to your institution?

Let’s talk about traction, clinical evidence and regulatory roadmap for clinics, hospitals and health institutions.

Go to Investors